sakuranetin has been researched along with Acute Lung Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bittencourt-Mernak, MI; Câmara, NO; Caperuto, LC; Felizardo, RJ; Grecco, SS; Guerreiro, MP; Lago, JH; Martins, MA; Pinheiro, NM; Prado, CM; Santana, FP; Saraiva-Romanholo, BM; Tibério, IF | 1 |
1 other study(ies) available for sakuranetin and Acute Lung Injury
Article | Year |
---|---|
Prophylactic and therapeutic treatment with the flavonone sakuranetin ameliorates LPS-induced acute lung injury.
Topics: Acute Lung Injury; Animals; Biomarkers; Cell Polarity; Collagen; Compliance; Cytokines; Flavonoids; Inflammation Mediators; Leukocytes; Lipopolysaccharides; Lung; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Models, Biological; Oxidative Stress; Phosphorylation; Pneumonia; Protein Subunits; RNA, Messenger; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA | 2017 |